Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letter
Nature Genetics  14, 203 - 205 (1996)
doi:10.1038/ng1096-203

Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene

Struan F. A. Grant1, David M. Reid1, Glen Blake2, Ruth Herd2, Ignac Fogelman2 & Stuart H. Ralston1, 3

  1Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB9 2ZD, UK

  2Department of Nuclear Medicine, Guy's Hospital, London SE1 2RT, UK

  3e-mail:s.ralston@abdn.ac.uk

Osteoporosis is a common disease with a strong genetic component1−3, characterized by reduced bone mass and increased fracture risk4. Current evidence suggests that the inheritance of bone mass is under polygenic control5 but the genes responsible are poorly defined. Type I collagen is the major protein of bone encoded by the COLIA1 and COLIA2 genes. While these are strong candidates for the genetic regulation of bone mass, no abnormality of either gene has so far been defined in osteoporosis6. In this study, we describe a novel Gright arrowT polymorphism in a regulatory region of COLIA1 at a recognition site for the transcription factor Sp17 that is significantly related to bone mass and osteoporotic fracture. G/T heterozygotes at the polymorphic Sp1 site (Ss) had significantly lower bone mineral density (BMD) than G/G homozygotes (SS) in two populations of British women and BMD was lower still in T/T homozygotes (ss). The unfavourable Ss and ss genotypes were over-represented in patients with severe osteoporosis and vertebral fractures (54%), as compared with controls (27%), equivalent to a relative risk of 2.97 (95% confidence interval 1.63−9.56) for vertebral fracture in individuals who carry the 's' allele. While the mechanisms that underlie this association remain to be defined, the COLIA1 Sp1 polymorphism appears to be an important marker for low bone mass and vertebral fracture, raising the possibility that genotyping at this site may be of value in identifying women who are at risk of osteoporosis.


REFERENCES
  1. Sorako, S.B., Barret-Connor, E., Edelstein, S.L. & Kritz-Silverstein, D. Family history of osteoporosis and bone mineral density at the axial skeleton: The Rancho Bernardo study. J. Bone Miner. Res. 9, 761−769 (1994). | PubMed  |
  2. Pocook, N.A., Eisman, J.A., Hopper, J.L., Yeates, M.G., Sambrook, P.N. & Eberl, S. Genetic determinants of bone mass in adults: a twin study. J. Clin. Invest. 80, 706−710 (1987). | PubMed  | ISI | ChemPort |
  3. Smith, D.M., Nance, W.E., Kang, K.W., Christian, J.C. & Johnston, C.C. Genetic factors in determining bone mass. J. Clin. Invest. 52, 2800−2808 (1973). | PubMed  | ISI | ChemPort |
  4. Kanis, J.A., Melton, L.J., Christiansen, C., Johnston, C.C. & Khaltaev, N. The diagnosis of osteoporosis. J. Bone Miner. Res. 9, 1137−1141 (1994). | PubMed  | ISI | ChemPort |
  5. Gueguen, R., Jouanny, P., guillemin, F. Kuntz, C., Pourel, J. & Siest, G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J. Bone Miner. Res. 12, 2017−2022 (1995).
  6. Spotila, L.D. et al. Mutation analysis of coding sequences for type I procollagen in individuals with low bone density. J. Bone Miner. Res. 9, 923−932 (1994). | PubMed  | ISI | ChemPort |
  7. Kadonga, J.T., Jones, K.A. & Tijan, R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem. Sci. 11, 20−23 (1986). | Article |
  8. Morrison, N.A. et al. Prediction of bone density from vitamin D receptor alleles. Nature 367, 284−287 (1994). | Article | PubMed  | ISI | ChemPort |
  9. Spector, T.D. et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. Br. Med. J. 310, 1357−1360 (1995). | ISI | ChemPort |
  10. Peacock, M. Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J. Bone Miner. Res. 10, 1294−1297 (1995). | PubMed  | ISI | ChemPort |
  11. Eisman, J.A. Vitamin D receptor gene alleles and osteoporosis: an affirmative view. J. BoneMiner. Res. 10, 1289−1293 (1995). | ChemPort |
  12. Mundy, G.R. Boning up on genes. Nature 367, 216−217 (1994). | Article | PubMed  | ISI | ChemPort |
  13. Rowe, D.W. in Bone and Mineral Research (eds Heersche, J.N.M. & Kanis, J.A.) 209−241 (Elsevier, Amsterdam, 1991).
  14. Sykes, B. Bone disease cracks genetics. Nature 348, 18−20 (1990). | Article | PubMed  | ISI | ChemPort |
  15. Prockop, D.J. et al. Type I procollagen: The gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue. Am. J. Hum. Genet. 34, 60−67 (1989). | ChemPort |
  16. Spotila, L.D., Constantinou, C.D., Sereda, L., Ganguly, A., Riggs, B.L. & Prockop, D.J. Mutation in the gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for a phenotypic and genotypic overlap wrth mild osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 88, 5243−5427 (1991).
  17. Chu, M.L., de Wet, W., Bernard, M. & Ramirez, F. Fine structural analysis of the human pro alpha-1 (l) collagen gene. J. Biol. Chem. 260, 2315−2320 (1985). | PubMed  | ISI | ChemPort |
  18. Rossouw, C.M.S., Vergeer, W.P., du Plooy, S.J., Bernard, M.P., Ramirez, F. & de Wet, W.J. DNA sequences in the first intron of the human pro-alpha-1 (I) collagen gene enhance transcription. J. Biol. Chem. 262, 15151−15157 (1987). | PubMed  | ISI | ChemPort |
  19. Seeman, E. et al. Reduced bone mass in daughters of women with osteoporosis. New Engl. J. Med. 320, 554−558 (1989). | PubMed  | ISI | ChemPort |
  20. Kobayashi, S., Inoue, S., Hosoi, T., Ouchi, Y., Shiraki, M. & Orimo, H. Association of bone minerai density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res. 11, 306−311 (1996). | PubMed  | ISI | ChemPort |
  21. Keen, R.W., Woodford-Richens, K.L., Lanchbury, J.S. & Spector, T.D. Peak bone mass, early postmenopausal bone loss and polymorphism at the oestrogen receptor gene. Osteoporosis Int. 6, 102 (1996).
  22. Qi, J.C. et al. Estrogen receptor genotypes and bone mineral density in women and men. J. Bone Miner. Res. 10, s170 (1995).
  23. Uittertinden, A.G. et al. Sp1 binding site potymorphism in the COLIA1 gene is associated with BMD: the Rotterdam study. Osteoporosis Int. 6, 124 (1996).
  24. Cooper, C. & Melton, L.J. Vertebral fractures. Br. Med. J. 304, 793−794 (1992). | ISI | ChemPort |
  25. Garton, M. et al. Bone mineral density and metabolism in premenopausal women taking thyroxine. Clin. Endocr. 41, 747−755 (1995). | ISI |
  26. Orita, M., Iwahana, H., Kanazana, H., Hayashi, K. & Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single stranded conformational polymorphisms. Proc. Nati. Acad. Sci. USA 86, 2766−2770 (1993).
  27. Chodosh, L.A. in Short Protocols in Molecular Biology Vol. 2 (eds Ausubel, F.M. et al.) 12-5−12-8 (Wiley, New York, 1992).
  28. Andrews, N.A. & Faller, D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limited numbers of mamalian cells. Nucl. Acids Res. 19, 2499 (1991). | PubMed  | ISI | ChemPort |
  29. Meyer, M., Schreck, R. & Baeuerte, P.A. H2O2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as a secondary antioxidant-responsive factor. EMBO J. 12, 2005−2015 (1993). | PubMed  | ISI | ChemPort |
 Top
 Top
References
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy